Skip to main content
biote Corp. (BTMD)
NASDAQ: BTMD · Real-Time Price · USD
5.00
-0.22 (-4.21%)
Oct 3, 2024, 4:00 PM EDT - Market closed

biote Revenue

biote had revenue of $49.17M in the quarter ending June 30, 2024, a decrease of -0.18%. This brings the company's revenue in the last twelve months to $187.23M, up 3.70% year-over-year. In the year 2023, biote had annual revenue of $185.36M with 12.37% growth.

Revenue (ttm)
$187.23M
Revenue Growth
+3.70%
P/S Ratio
0.93
Revenue / Employee
$965,119
Employees
194
Market Cap
154.97M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023185.36M20.40M12.37%
Dec 31, 2022164.96M25.56M18.34%
Dec 31, 2021139.40M22.83M19.58%
Dec 31, 2020116.57M6.59M5.99%
Dec 31, 2019109.98M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accuray 446.55M
High Tide 370.02M
TruBridge 336.56M
The Joint 120.07M
Compugen 42.72M
Caribou Biosciences 33.11M
Sangamo Therapeutics 12.28M
Lineage Cell Therapeutics 6.19M
Revenue Rankings

BTMD News

More News